Searched for
RANJANA SMETACEK
Changes proposed in norms to speed up approvals for biosimilarsBiosimilars are copies of complex drugs based on living cells. They are different from chemical-based generic drugs, which are 'identical' ...- Pharma practices code rollout deferred againThe government has postponed by another three months the implementation of a statutory code of principles to curb unethical practices.
- Withdrawing customs duty may lead to hike in medicine prices: DG ShahThe Central Board of Excise and Customs (CBEC) last week issued a notification withdrawing exemption of levy of basic customs duty on as ma...
- Pharma companies team up to clean industry’s image, push for ethical marketing practicesThe ‘Forum of Pharmaceutical Ethical Marketing Practices’ will draw a core working group from the firms to decide the modalities of taking ...
- Pharma industry demands increase in public spending on healthcareThe Centre is already seeking to overhaul the health system with an aim to advance universal health coverage and focus on social indicators...
- Three areas pharma companies want Budget to focus onThere are has high expectations from the upcoming Budget, especially for the pharmaceutical industry, said Ranjana Smetacek of OPPI.
- Foreign pharma firms make pitch for easing FDI normsAhead of US President Barack Obama’s visit, OPPI has urged govt to allow inclusion of non-complete clauses when it comes to M&As.
- Foreign drug makers urge government to review IPR think tankA similar point has also been raised by the US biotech groupings PhRMA and BIO in their submissions to the US Trade Representative's office.
- Committed to quality and accessible healthcare services: OPPIOPPI, which represents research-driven pharma companies in India, has continued its advocacy for an environment that allows innovation in m...
- OPPI asks Department of Pharmaceuticals to make Uniform Code of Pharmaceutical Marketing Practices a statutory codeThis would lead to increased levels of transparency and accountability across the healthcare industry and remove ambiguity.
- Random decisions in pharma pricing bad for India’s healthThe decision goes against the National Pharmaceutical Pricing Policy (NPPP) 2012, which was deliberated by a group of ministers and approve...
- Price controls: Pharma industry favours dialogue with governmentHC order brings 120 anti-diabetic formulation packs & 247 cardiovascular formulation packs under price control disappointing pharma industr...
- Pharma companies ready to be 'healthy' ally to meet medicare goalsThe Pharmaceutical industry today said it is willing to partner with the government for achieving the vision of "healthcare access for all".
- Organisation of Pharma Producers of India challenges NPPA's decision to bring more drugs under price control in High CourtThis is second suit NPPA is facing on matter after India Pharma Alliance (IPA), a grouping of large domestic drugfirms filed a petition .
- Budget 2014: Pharma industry's expectationsA holistic approach is needed to expand healthcare in India and OPPI believes that there is a need to balance innovation with access and af...
- Will India achieve pharma vision 2020?The government is committed to making India one of the world’s leading destinations for end-to-end drug discovery and innovation by 2020.
- New caveat in drug FDI policy worries MNCsValuations of Indian pharmaceutical companies may drop with the government deciding to bar non-compete clauses in takeovers by foreign comp...
- Pharma sector in good health, to create more jobs: ExpertsIndian as well as multinational pharmaceutical companies are likely to create more jobs in 2014 on the back of expected double digit growth...
Load More
